Why are Women With Polycystic Ovary Syndrome at Increased Risk of Depression? Exploring the Etiological Maze

被引:12
|
作者
Gnawali, Anupa [1 ]
Patel, Viral [2 ]
Cuello-Ramirez, Alejandrina [3 ]
Al Kaabi, Anoud S. [4 ]
Noor, Asfa [2 ]
Rashid, Mohammed Y. [5 ]
Henin, Shereen [6 ]
Mostafa, Jihan A. [7 ]
机构
[1] Calif Inst Behav Neurosci & Psychol, Family Med, Fairfield, CA 94534 USA
[2] Calif Inst Behav Neurosci & Psychol, Res, Fairfield, CA USA
[3] Calif Inst Behav Neurosci & Psychol, Internal Med, Fairfield, CA USA
[4] Calif Inst Behav Neurosci & Psychol, Neonatol, Fairfield, CA USA
[5] Calif Inst Behav Neurosci & Psychol, Gen Surg, Fairfield, CA USA
[6] Calif Inst Behav Neurosci & Psychol, Internal Med, Pediat, Fairfield, CA USA
[7] Calif Inst Behav Neurosci & Psychol, Psychiat, Fairfield, CA USA
关键词
insulin resistance; hyperandrogenism; menstrual irregularities; polycystic ovary syndrome (pcos); depression; QUALITY-OF-LIFE; INSULIN-RESISTANCE; OBESITY; INFERTILITY; PARAMETERS; SYMPTOMS; ANXIETY; ASSOCIATIONS; PREVALENCE; EXPERIENCE;
D O I
10.7759/cureus.13489
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Polycystic ovary syndrome (PCOS) is a complex and common multisystemic disorder. Women with PCOS have up to eight times higher prevalence of depression than control groups. This paper aims to explore the underlying risk factors for developing depression in this high-risk group. Studies indicate an interplay of multiple mechanisms that place women with PCOS at an increased risk for depression. The pathophysiology thought to play a role includes disturbances in the endocrine axes and changes to the metabolic pathway. The risk of depression is independently linked to insulin resistance and obesity in this population. However, rates of depression were still higher than control groups when accounting for these variables, demonstrating that they are not the only mechanism causing depression. The clinical manifestations of hyperandrogenism and menstrual abnormalities may compound negative views and lower self-esteem and negatively impact mood. Many of these women also struggle with infertility, and due to the added external pressures like societal beliefs and culture, they may be further negatively impacted and worsen their depressive symptoms. The prevalence of depression in women with PCOS is high; thus, this paper highlights the essential understanding of the underlying mechanisms at play. This is to better aid in addressing the fundamental cause of depression in this high-risk group effectively.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Increased risk of depressive disorders in women with polycystic ovary syndrome
    Hollinrake, Elizabeth
    Abreu, Alison
    Maifeld, Michelle
    Van Voorhis, Bradley J.
    Dokras, Anuja
    FERTILITY AND STERILITY, 2007, 87 (06) : 1369 - 1376
  • [22] Metformin Improves the Depression Symptoms of Women with Polycystic Ovary Syndrome in a Lifestyle Modification Program
    AlHussain, Fatimah
    AlRuthia, Yazed
    Al-Mandeel, Hazem
    Bellahwal, Arwa
    Alharbi, Fadia
    Almogbel, Yasser
    Awwad, Oriana
    Dala'een, Roua
    Alharbi, Fawaz Abdullah
    PATIENT PREFERENCE AND ADHERENCE, 2020, 14 : 737 - 746
  • [23] Obesity and hyperandrogenism are implicated with anxiety, depression and food cravings in women with polycystic ovary syndrome
    Stefanaki, Katerina
    Karagiannakis, Dimitrios S. S.
    Raftopoulou, Marina
    Psaltopoulou, Theodora
    Paschou, Stavroula A. A.
    Ilias, Ioannis
    ENDOCRINE, 2023, 82 (01) : 201 - 208
  • [24] Anxiety, depression, and body image among infertile women with and without polycystic ovary syndrome
    Jannink, T.
    Bordewijk, E. M.
    Aalberts, J.
    Hendriks, J.
    Lehmann, V
    Hoek, A.
    Goddijn, M.
    van Wely, M.
    HUMAN REPRODUCTION, 2024, 39 (04) : 784 - 791
  • [25] Physical activity and mental health in women with Polycystic Ovary Syndrome
    Banting, Lauren K.
    Gibson-Helm, Melanie
    Polman, Remco
    Teede, Helena J.
    Stepto, Nigel K.
    BMC WOMENS HEALTH, 2014, 14
  • [26] Metformin use in women with polycystic ovary syndrome
    Johnson, Neil P.
    ANNALS OF TRANSLATIONAL MEDICINE, 2014, 2 (06)
  • [27] Cardiovascular risk in women with polycystic ovary syndrome
    Giallauria, Francesco
    Orio, Francesco
    Palomba, Stefano
    Lombardi, Gaetano
    Colao, Annamaria
    Vigorito, Carlo
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2008, 9 (10) : 987 - 992
  • [28] Risk of Periodontal Diseases in Women With Polycystic Ovary Syndrome: An Overview
    Rathi, Netal
    Reche, Amit
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [29] Hepatic steatosis in women with polycystic ovary syndrome
    Hong, Xinyu
    Guo, Zaixin
    Yu, Qi
    BMC ENDOCRINE DISORDERS, 2023, 23 (01)
  • [30] Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome
    Cinar, Nese
    Kizilarslanoglu, Muhammed Cemal
    Harmanci, Ayla
    Aksoy, Duygu Yazgan
    Bozdag, Gurkan
    Demir, Basaran
    Yildiz, Bulent Okan
    HUMAN REPRODUCTION, 2011, 26 (12) : 3339 - 3345